Arecor Therapeutics plc (AREC) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arecor Therapeutics Plc.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04264-226b-7f52-a6fc-c4b1a3aa6a94 Created: 2026-08-27T08:44:17.179Z Duration: 2836.848 Channels: 1 00:00:00.480 -- 00:00:02.800 Good morning, and welcome to the Arecor Therapeutics 00:00:02.800 -- 00:00:04.560 plc investor presentation. 00:00:04.640 -- 00:00:06.640 Throughout this quarter presentation, investors will be in 00:00:06.640 -- 00:00:08.720 listen only mode. Questions are encouraged and can 00:00:08.720 -- 00:00:10.160 be submitted at any time via the Q 00:00:10.160 -- 00:00:11.679 and A tab situated on the right hand 00:00:11.679 -- 00:00:13.519 corner of your screen. Simply type in your 00:00:13.519 -- 00:00:15.725 questions and press send. Before we begin, I'd 00:00:15.725 -- 00:00:17.085 like to make the following poll. 00:00:17.805 -- 00:00:19.005 And I'd to hand you over to the 00:00:19.005 -- 00:00:21.885 executive management team from Arecor Therapeutics plc. Sarah, 00:00:21.885 -- 00:00:22.605 good morning. 00:00:23.005 -- 00:00:25.485 Thank you. Good morning. Good morning, everybody. Thank 00:00:25.485 -- 00:00:27.485 you for taking the time to join us 00:00:27.485 -- 00:00:29.970 today. So name is Doctor Sarah Howell. I'm 00:00:29.970 -- 00:00:32.850 the CEO of Arecor Therapeutics, and I'm joined 00:00:32.850 -- 00:00:33.490 today 00:00:33.650 -- 00:00:36.050 by David Ellen, our CFO, who will be 00:00:36.050 -- 00:00:39.170 talking you through the full year results 00:00:39.330 -- 00:00:43.425 until 12/31/2025. 00:00:43.425 -- 00:00:46.145 So our customary legal notice. 00:00:47.425 -- 00:00:49.745 So at Arecor, we're very much focused just 00:00:49.745 -- 00:00:51.105 as a quick recap. 00:00:51.345 -- 00:00:53.825 We're a clinical stage biotech company, as you 00:00:53.825 -- 00:00:5...